January 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreDecember 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreFebruary 05, 2026
According to our forecasts, the humanized monoclonal antibody market was valued at USD 170.04 billion in 2025 and is projected to reach USD 190.34 billion in 2026, expanding to USD 525.3 billion by 2035 at a CAGR of 11.94% from 2026 to 2035....
February 04, 2026
According to our projections, the chlorogenic acid API market was valued at USD 150 million in 2025 and is projected to grow from USD 154.58 million in 2026 to USD 202.57 million by 2035, registering a CAGR of 3.05% during the forecast period....
February 04, 2026
According to our projections, the chronic pain therapy solutions for joints market was valued at USD 5.15 billion in 2025 and reached USD 5.4 billion in 2026, with projections indicating growth to USD 8.28 billion by 2035, expanding at a CAGR of 4.86% from 2026 to 2035....
February 04, 2026
Based on our research, the healthcare CDMO market was valued at USD 306.3 billion in 2025 and reached USD 337.3 billion in 2026, and it is projected to expand to USD 803.17 billion by 2035, growing at a CAGR of 10.12% during 2026–2035....
February 04, 2026
According to market research studies, the global oral Factor Xa inhibitors market was valued at USD 21.5B in 2023 and is projected to reach USD 41.24B by 2034, growing at a CAGR of 6.1%, driven by rising cardiovascular cases, ease of use, and increasing adoption of drugs like apixaban and rivaroxaban....
February 04, 2026
According to forecasts, the global active pharmaceutical ingredients market will grow from USD 219.7 billion in 2025 to USD 418.64 billion by 2035, with an expected CAGR of 6.66%. In 2022, North America led the global active pharmaceutical ingredients (API) market with $78.19 billion, while Asia Pacific is set for the fastest growth at 7.08% CAGR t...
February 03, 2026
According to our projections, the autologous CAR-T cell therapy market was valued at USD 5.35 billion in 2025 and is expected to reach USD 6.53 billion in 2026, further expanding to USD 39.53 billion by 2035, growing at a CAGR of 22.14% from 2026 to 2035....
February 03, 2026
Based on market forecasts, the global Non-steroidal anti-inflammatory drugs market, projected at USD 23.16 billion in 2025, is expected to reach USD 37.73 billion by 2035, growing at a CAGR of 5% over the forecast period. Arthritis dominated the NSAIDs market with a 38% share. Oral administration was the top choice (56%) for its ease of use. Retail...
February 02, 2026
According to our projections, the biosimilar monoclonal antibodies market is projected to reach USD 19.78 billion in 2026, expanding to approximately USD 129.61 billion by 2035 at a CAGR of 23.23%....
January 30, 2026
Based on market forecasts, the global heartworm treatment products market, projected at USD 1.55 billion in 2025, is expected to reach USD 3.06 billion by 2035, growing at a CAGR of 7.04% over the forecast period. The global market is propelled by the growing pet ownership and demand for awareness about heartworm treatments. The presence of well-de...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com